Kate RochlinChief Operating Officer at IN8bio, USA
Agenda Sessions
Maintaining Both Innate Killing & Specific Targeting of Heterogeneous Tumours with Chemotherapy-Resistant Chlorotoxin CAR-T Cells
, 5:15pmView Session